| Literature DB >> 30966414 |
Ying Zhang1,2, Zhiping Zhou3, Mingsheng Chen4.
Abstract
The major challenges of non-viral carriers are low transfection efficiency and highEntities:
Keywords: biocompatible polypeptides; controlled polymerization; gene delivery; hydrophobic chain; structure-property-function; transfection efficiency
Year: 2018 PMID: 30966414 PMCID: PMC6415248 DOI: 10.3390/polym10040379
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Synthesis route of controlled di-block amphiphilic poly(l-lysine)50-block-poly(l-leucine)n.
Figure 21H NMR spectrum of l-lysine(CBZ)-NCA and l-leucine-NCA in DMSO-d6.
Results of polymerization.
| Entry | Mn. Theory (×103 g/mol) | Mn a (×103 g/mol) | Mw/Mn | Conv. b | The Final Products | The Proportion of Hydrophobic Domains |
|---|---|---|---|---|---|---|
| Poly( | 13.1 | 13.2 | 1.10 | >99% | N/A | N/A |
| Poly( | 14.2 | 14.4 | 1.14 | >99% | Poly( | 15.1% |
| Poly( | 14.7 | 14.8 | 1.27 | >99% | Poly( | 20.9% |
| Poly( | 15.9 | 15.8 | 1.3 | >99% | Poly( | 30.6% |
a determined by SEC; b determined by IR at 1791 cm−1.
Figure 31H NMR spectrum of (I): poly(l-lysine)50-block-poly(l-leucine)10 in DMSO-d6 and (II): poly(l-lysine(CBZ))50-block-poly(l-leucine)10 in D2O.
Figure 4Self-assembling of pDNA and polypeptides: (A) transmission electron microscopy of poly(l-lysine)50-block-poly(l-leucine)15/pDNA at the N/P = 15; (B) DLS of (a) poly(l-lysine)50-block-poly(l-leucine)25, (b) poly(l-lysine)50-block-poly(l-leucine)15, and (c) poly(l-lysine)50-block-poly(l-leucine)10 mixed with pDNA at the N/P = 15; and (C) agarose gel electrophoresis of poly(l-lysine)50-block-poly(l-leucine)15/pDNA at various N/P ratios.
Figure 5(A) Zeta potential of polyplexes of plasmid DNA and (a) poly(l-lysine)50-block-poly(l-leucine)10, (b) poly(l-lysine)50-block-poly(l-leucine)15, (c) poly(l-lysine)50-block-poly(l-leucine)25 at different N/P ratio; and (B) polyplexes of poly(l-lysine)50-block-poly(l-leucine)25/DNA digested by trypsin (0.25%) at 37 °C at various time.
Figure 6Confocal laser scanning microscopy (CLSM) images of Bel-7402 cells incubated by RB-labelled poly(l-lysine)50-block-poly(l-leucine)15/DNA.
Figure 7Toxicity assessment of nanocomposites of plasmid DNA and (a) poly(l-lysine)50-block-poly(l-leucine)10, (b) poly(l-lysine)50-block-poly(l-leucine)15, (c) poly(l-lysine)50-block-poly(l-leucine)25, and control (PEI, 25 K) by using COS-7 cells at various N/P (mean ± SD, n = 3).
Figure 8Gene transfection of (a) poly(l-lysine)50-block-poly(l-leucine)10, (b) poly(l-lysine)50-block-poly(l-leucine)15, (c) poly(l-lysine)50-block-poly(l-leucine)25 at their optimized N/P ratio (N/P = 15) in different cell lines (Student’s t-test, * p < 0.05; ** p < 0.01) (mean ± SD, n = 3).